TaeWoong Medical Co. Ltd. was founded in 1991 and obtained CE approval for the excellence of Niti-S™ brand products through product quality and technical expertise.
We started business and experienced continuous growth and successfully obtained product qualification certificates in Japan, USA, China, Canada, Russia, and other countries. We continue to expand and currently export to more than 70 countries.
With patient outcomes in mind, our innovative products allow physicians to perform simple and complex procedures. Pioneers of the TTS, “through the scope” technology, the TaeWoong Esophageal TTS Stent is the only choice for treatment of esophageal strictures.* View analysis and evidence of the potential clinical, economic, and successful patient outcomes of utilizing this first in class technology.
Indication for use: The Esophageal TTS Stent is intended for use in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors.
Pioneers of the TTS (through the scope technology). We are the first company to offer esophageal TTS stents in the US, bringing you the latest advancements in GI care, The TaeWoong Esophageal TTS Stent offers a variety of ways to treat patients.
Indicated for malignant biliary strictures. Featuring an unfixed cell design, the Niti-S Biliary Stent offers minimal foreshortening and accurate positioning. The optimal combination of radial and axial force allows for luminal patency in tortuous anatomy.
